UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Grid Dynamics Holdings
GDYN
$615M
| $1.3M | ﹤0.01% |
124,161
+39,765
| +47% | +$410K |
|
2202
Acco Brands
ACCO
$407M
| $1.3M | ﹤0.01% |
276,805
+173,851
| +169% | +$867K |
|
2203
Malibu Boats
MBUU
$567M
| $1.3M | ﹤0.01% |
37,074
+24,152
| +187% | +$883K |
|
2204
FIGS
FIGS
$2.37B
| $1.3M | ﹤0.01% |
243,320
+125,564
| +107% | +$642K |
|
2205
Seadrill
SDRL
$2.7B
| $1.29M | ﹤0.01% |
+25,126
| New | +$1.27M |
|
2206
ZipRecruiter
ZIP
$423M
| $1.29M | ﹤0.01% |
142,240
+76,974
| +118% | +$777K |
|
|
PGRE
2207
DELISTED
Paramount Group
PGRE
| $1.29M | ﹤0.01% |
278,772
-905,528
| -76% | -$4.2M |
|
|
SPNS
2208
DELISTED
Sapiens International
SPNS
| $1.29M | ﹤0.01% |
37,883
+29,554
| +355% | +$964K |
|
2209
Smith & Wesson
SWBI
$637M
| $1.28M | ﹤0.01% |
89,050
+62,807
| +239% | +$1.03M |
|
2210
Forestar Group
FOR
$1.51B
| $1.28M | ﹤0.01% |
39,917
+12,443
| +45% | +$421K |
|
2211
XBiotech
XBIT
$69.2M
| $1.28M | ﹤0.01% |
+248,270
| New | +$1.91M |
|
2212
Ichor Holdings
ICHR
$2.56B
| $1.28M | ﹤0.01% |
33,094
+3,962
| +14% | +$151K |
|
2213
Ocular Therapeutix
OCUL
$2.02B
| $1.27M | ﹤0.01% |
+186,060
| New | +$1.15M |
|
|
PETQ
2214
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.27M | ﹤0.01% |
+57,467
| New | +$1.1M |
|
2215
Quanex
NX
$1.01B
| $1.27M | ﹤0.01% |
45,807
+19,553
| +74% | +$647K |
|
2216
Evolus
EOLS
$501M
| $1.26M | ﹤0.01% |
116,532
+49,785
| +75% | +$612K |
|
2217
Janux Therapeutics
JANX
$967M
| $1.26M | ﹤0.01% |
30,178
+21,483
| +247% | +$1.01M |
|
2218
Pliant Therapeutics
PLRX
$65M
| $1.26M | ﹤0.01% |
117,482
+45,363
| +63% | +$585K |
|
2219
Dr. Reddy's Laboratories
RDY
$10.2B
| $1.26M | ﹤0.01% |
82,790
-69,270
| -46% | -$993K |
|
|
PMT
2220
PennyMac Mortgage Investment
PMT
$842M
| $1.26M | ﹤0.01% |
91,701
-50,491
| -36% | -$708K |
|
|
SILV
2221
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $1.26M | ﹤0.01% |
+153,995
| New | +$1.26M |
|
2222
BW LPG
BWLP
$3.3B
| $1.25M | ﹤0.01% |
+65,666
| New | +$1.16M |
|
2223
iShares MSCI Emerging Markets ETF
EEM
$30B
| $1.25M | ﹤0.01% |
+29,300
| New | +$1.23M |
|
|
FBMS
2224
DELISTED
The First Bancshares, Inc.
FBMS
| $1.25M | ﹤0.01% |
48,028
+17,379
| +57% | +$428K |
|
2225
Liquidity Services
LQDT
$1.32B
| $1.25M | ﹤0.01% |
62,320
+34,835
| +127% | +$652K |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.